A detailed history of Truvestments Capital LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 4,848 shares of ORGO stock, worth $21,961. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,848
Previous 3,913 23.89%
Holding current value
$21,961
Previous $14,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$3.78 - $5.03 $3,534 - $4,703
935 Added 23.89%
4,848 $21,000
Q2 2025

Aug 13, 2025

BUY
$2.66 - $5.34 $10,408 - $20,895
3,913 New
3,913 $14,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $593M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.